Why Adding Skechers (SKX) May Hurt Your Portfolio's Return
Zacks Investment Research | Dec 02, 2016 04:02AM ET
Adding profitable and recommended stocks to your portfolio is a wise decision. Also, disposing of underperforming stocks is equally important in order to safeguard your portfolio returns. Skechers U.S.A., Inc. (NYSE:SKX) is one such stock which should not be part of your portfolio, at least for the time being.
This Zacks Rank #4 (Sell) stock, which closed at $26.40 on the last trading day, has declined nearly 17.1% in the past six months. Additionally, it has underperformed the Zacks Categorized Apparel industry, which fell 7.9% over the same time frame. Let’s explore more to find out what’s weighing upon investors’ sentiments.
Skechers continued with its dismal performance in 2016, with its lackluster third-quarter figures. Both the company’s top and bottom lines missed estimates and earnings fell on a year-over-year basis. This footwear retailer witnessed negative earnings surprises of 5.9% and 8.7% in the second and third quarters, respectively. On the other hand, its revenues missed the estimate for the second straight quarter.
Skechers’ earnings were impacted by foreign currency headwinds, rise in general and administrative expenses and higher effective tax rate. In addition, the company’s domestic wholesale business remained a drag in the quarter. Further, the rate of sales growth in the third quarter (up 10.1%) and the second quarter (up 9.7%) declined significantly from the first quarter (up 27.4%). (Read more: Skechers Misses on Q3 Earnings & Sales; Stock Down )
Consequently, management issued a bleak outlook for fourth-quarter 2016. It now projects net sales in the band of $710–$735 million.
Moreover, the lower-than-expected results, along with a soft projection, triggered a downtrend in estimates. Over the past 60 days, the Zacks Consensus Estimate of $1.61 and $1.68 for 2016 and 2017 decreased 16 cents and 24 cents, respectively. Further, the Zacks Consensus Estimate of 8 cents for fourth-quarter 2016 declined by 13 cents over the same time frame.
SKECHERS USA-A Price and Consensus
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .
Steven Madden, with a long-term earnings growth rate of 13.5%, has gained 25.4% year to date.
Caleres, with a long-term earnings growth rate of 11%, has jumped nearly 30.2% in the past six months.
Get The News You Want
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.